packageRoflumilast

roflumilast

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Roflumilast is used to treat chronic obstructive pulmonary disease and, as a topical preparation, psoriasis. It is authorised in the European Union for COPD and is an approved medicine, though some EU products have been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q693482 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:roflumilast
ATC codes:D05AX06, R03DX07
DrugBank:DB01656
PubChem CID:449193
ChEBI:47657
Wikidata:Q693482
formula:C17H14Cl2F2N2O3
molar mass:403.206 g/mol (PubChem CID 449193)
logP:4.6 (Drugs.Common 25.09, not verified)

Metabolites

RoflumilastNOxideroflumilast N-oxide419.205 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
RoflumilastNOxidemetabolite: roflumilast N-oxide